The Bio Convergence company

Bico by the numbers

Future. Forward. Fast

  • Net sales Q1-Q3, 2021
    0 MUSD
  • Organic growth Q1-Q3, 2021
    0 %
  • Employees
    0 +
  • Instruments in the field
    0 +
  • Publications
    0 +
  • Countries
    0 +

Trusted by
industry leaders

grey-lor
grey-johnson-johnson
grey-logo-karolinska-institutet
grey-astra_c
grey-harvard-1
grey-merck
grey-roche2
grey-amgen
grey-mit_s
grey-shiseido
grey-novaratis
grey-3M
grey-genetech
grey-bristol myers
grey-celgene
grey-takeda
grey-novo nordisk
grey-boehringer-ingelheim

Business areas

Revolutionizing Science

With over 25,000 instruments in the field, our products are used in more than 2,500 laboratories including the world’s top 20 leading pharmaceutical companies, in more than 65 countries and have been cited in more than 9,500 publications.

Making the seemingly impossible, possible

Focusing on bioprinting, multiomics, cell line development and diagnostics, we enable researchers to grow cells in 3D environments, conduct high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical and cosmetic industries.

Revolutionizing Science

With over 25,000 instruments in the field, our products are used in more than 2,500 laboratories including the world’s top 20 leading pharmaceutical companies, in more than 65 countries and have been cited in more than 9,500 publications.

Making the seemingly impossible, possible

Focusing on bioprinting, multiomics, cell line development and diagnostics, we enable researchers to grow cells in 3D environments, conduct high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical and cosmetic industries.

press releases

BICO in the press

11/26/21 Nordic Life Science NewsThese are the 5 nominees for the SwedenBIO Award
09/01/21 Genetic Engineering & Biotechnology NewsBuying Spree: Rebranded BICO Bets Big on “Bioconvergence”
08/31/21 San Diego Business JournalAdvanced BioMatrix Acquired by BICO for $15M
08/20/21 Nordic Life Science NewsCELLINK rebrands itself to BICO

Calendar

November 10, 2021Q3 report 2021
February 23, 2022Year-end report 2021
March 16, 2022Annual report 2021

Contact us

    • Investor relations

    • Isabelle Ljunggren, Head of Communications
    • Email: il@bico.com
    • Sales

    • Visit our subsidiaries' websites to explore our product offering.

Press room